Telix Pharmaceuticals (ASX:TLX) Inventories, Inventories Adjustments: A$0 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ASX:TLX Telix Pharmaceuticals Ltd ASX:TLX
61 GF Score
Price A$15.65
GF Value A$36.59
Valuation Possible Value Trap
! 7 Warning Signs
View Full Analysis

What is Telix Pharmaceuticals Inventories, Inventories Adjustments?

Telix Pharmaceuticals ASX:TLX +0.45% 61 Inventories, Inventories Adjustments is A$0 Mil as of Jun. 2026. GuruFocus rates ASX:TLX with a GF Score™ of 61/100 and a GF Value™ of A$36.59 (Possible Value Trap). The stock has 7 warning signs investors should review.

Telix Pharmaceuticals's Inventories, Inventories Adjustments for the quarter that ended in Jun. 2026 was A$0 Mil.

Telix Pharmaceuticals's quarterly Inventories, Inventories Adjustments declined from Jun. 2025 (A$-12 Mil) to Dec. 2025 (A$-25 Mil) but then increased from Dec. 2025 (A$-25 Mil) to Jun. 2026 (A$0 Mil).

Telix Pharmaceuticals's annual Inventories, Inventories Adjustments declined from Dec. 2023 (A$0 Mil) to Dec. 2024 (A$-4 Mil) and declined from Dec. 2024 (A$-4 Mil) to Dec. 2025 (A$-25 Mil).

Telix Pharmaceuticals Inventories, Inventories Adjustments Historical Data

* Premium members only.

The historical data trend for Telix Pharmaceuticals's Inventories, Inventories Adjustments can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Telix Pharmaceuticals Inventories, Inventories Adjustments Chart

Telix Pharmaceuticals Annual Data
Trend Sep00 Jun17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Inventories, Inventories Adjustments
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 -4.07 -25.37

Telix Pharmaceuticals Semi-Annual Data
Sep00 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25 Jun26
Inventories, Inventories Adjustments Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 -4.07 -11.90 -25.37 0.00
ASX:TLX
61GF Score
Telix Pharmaceuticals Ltd ASX:TLX
Inventories, Inventories Adjustments is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Telix Pharmaceuticals Inventories, Inventories Adjustments Calculation

Inventories, Inventories Adjustments represents certain charges made in the current period in inventory resulting from breakage, spoilage, employee theft and shoplifting, etc.

What does a Inventories, Inventories Adjustments of A$0 Mil mean?
Telix Pharmaceuticals (ASX:TLX) has a Inventories, Inventories Adjustments of A$0 Mil as of Jun. 2026. Inventories, Inventories Adjustments is certain charges made in the current period in inventory resulting from breakage, spoilage, etc. View historical data on Telix Pharmaceuticals and its competitors.
Is Telix Pharmaceuticals' Inventories, Inventories Adjustments too high?
Telix Pharmaceuticals' current Inventories, Inventories Adjustments is A$0 Mil. Overall, Telix Pharmaceuticals has a GF Score™ of 61/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Telix Pharmaceuticals' Inventories, Inventories Adjustments compare to VRTX and REGN?
Telix Pharmaceuticals' Inventories, Inventories Adjustments of A$0 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Inventories, Inventories Adjustments for a Biotechnology company?
A good Inventories, Inventories Adjustments depends on the Biotechnology industry context. However, Inventories, Inventories Adjustments should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Inventories, Inventories Adjustments mean?
A high Inventories, Inventories Adjustments can signal that a stock is expensive relative to its fundamentals. Inventories, Inventories Adjustments is certain charges made in the current period in inventory resulting from breakage, spoilage, etc. View historical data on Telix Pharmaceuticals and its competitors. Telix Pharmaceuticals's current Inventories, Inventories Adjustments is A$0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Telix Pharmaceuticals stock overvalued right now?
Based on GuruFocus' analysis, Telix Pharmaceuticals (ASX:TLX) is currently considered Possible Value Trap. The stock's GF Value™ is A$36.59, compared to a current price of A$15.65 — trading 57.2% below its estimated fair value. The current Inventories, Inventories Adjustments is A$0 Mil. Telix Pharmaceuticals' overall GF Score™ is 61/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Inventories, Inventories Adjustments calculated?
Inventories, Inventories Adjustments is calculated from a company's financial statements. For Telix Pharmaceuticals (ASX:TLX), the current Inventories, Inventories Adjustments is A$0 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Telix Pharmaceuticals (ASX:TLX) Overvalued in 2026?

Based on GuruFocus' analysis, Telix Pharmaceuticals stock appears to be undervalued. The current stock price of A$15.65 is trading 57.2% below its estimated GF Value™ of A$36.59. GuruFocus considers Telix Pharmaceuticals to be Possible Value Trap.

Key valuation signals for ASX:TLX:

  • Inventories, Inventories Adjustments: A$0 Mil
  • GF Value™: A$36.59 vs. price of A$15.65 (57.2% below fair value)
  • GF Score™: 61/100 with 7 warning signs

No single metric tells the full story. See the ASX:TLX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Telix Pharmaceuticals Business Description

Other Exchanges TLX:USATLPPF:USAT3X:Germany
Address 55 Flemington Road, Level 4, North Melbourne, Melbourne, VIC, AUS, 3051
Telix develops radiopharmaceuticals to manage cancer. Radiopharmaceuticals are radioisotopes bound to molecules that can target specific cells. At low doses, these drugs can bind to specific cancer cells with radiation, and then positron emission tomography imaging can accurately visualize tumors. At high doses, these drugs can selectively target and treat tumors with radiation, known as radioligand therapy. Radiopharmaceuticals are usually injected into the bloodstream. Telix has a pipeline of potential radiopharmaceuticals but currently earns most of its revenue from US sales of Illuccix, largely used as an imaging agent to visualize the spread of prostate cancer.
61GF Score

Get the complete analysis for ASX:TLX

Inventories, Inventories Adjustments is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

A$15.65
Price
A$36.59
GF Value